Gravar-mail: HG-87 COMBINED APPLICATION OF TEMOZOLOMIDE AND THE ONCOLYTIC PARVOVIRUS H-1 INCREASES CYTOTOXIC EFFECTS IN CELL CULTURE AND ANIMAL MODELS OF PEDIATRIC GLIOBLASTOMA